Suchergebnisse - "Perrone, Francesco"

PubPharm (21)

1

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer : Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Morabito, A. | Piccirillo, M. | Maione, P. | +27

2

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer : Joint Analysis of MILES-3 and MILES-4 Phase III Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Gridelli, C. | Morabito, A. | Cavanna, L. | +27

CommentIn: J Clin Oncol. 2018 Sep 1;36(25):2571-2574. - PMID 30028655

3

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients : The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Morabito, A. | Daniele, G. | Costanzo, R. | +17

4

Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

enthalten in: Analytical cellular pathology (Amsterdam) | 2016

von Cavalcanti, E. | Barchiesi, V. | Cerasuolo, D. | +8

5

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer : a systematic review and meta-analysis of individual patient data

enthalten in: The Lancet. Oncology | 2014

von Rossi, A. | Chiodini, P. | Sun, J. | +11

CommentIn: Lancet Oncol. 2014 Oct;15(11):1187-8. - PMID 25232000

6

Treatment of small cell lung cancer

enthalten in: Critical reviews in oncology/hematology | 2014

von Morabito, A. | Carillio, G. | Daniele, G. | +9

7

Rationale and design of MILES-3 and MILES-4 studies : two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

enthalten in: Clinical lung cancer | 2014

von Gridelli, C. | Rossi, A. | Di Maio, M. | +14

8

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2013

von Reaume, M. | Leighl, N. | Mittmann, N. | +11

9

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2 : the CAPPA-2 study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2013

von Morabito, A. | Gebbia, V. | Di Maio, M. | +20

10

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Di Maio, M. | Leighl, N. | Gallo, C. | +26